Takeda Pharmaceutical Company Limited | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases Takeda Pharmaceutical Company Limited

Home
Companies
Takeda Pharmaceutical Company Limited

BRIEF

published on 10/31/2024 at 07:05, 21 days 3 hours ago

Takeda Revises FY2024 Financial Forecasts

Net Profit Growth Operating Profit Increase Takeda Financial Forecast FY2024 Revisions VYVANSE Impact
PRESS RELEASE

published on 10/31/2024 at 07:00, 21 days 3 hours ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2024 (IFRS)
Takeda Pharmaceutical revises FY2024 financial forecast, expecting growth in revenue and profit. Core metrics show positive trends. Details on the forecast and reasons for revision provided

Financials FY2024 Revised Forecast Takeda Pharmaceutical Core Metrics
BRIEF

published on 05/09/2024 at 08:05, 6 months 12 days ago

Takeda Launches Major Program to Boost Growth and Enhance Profit Margins

Takeda Pharmaceutical Growth Profit Margin Improvement Digital Investment Restructuring Costs
PRESS RELEASE

published on 05/09/2024 at 08:00, 6 months 12 days ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Announces Enterprise-wide Program to Support Growth and Deliver Core Operating Profit Margin Improvement
Takeda announces enterprise-wide program to support growth and deliver core operating profit margin improvement, focusing on organizational agility and leveraging data, digital, and technology capabilities

Takeda Pharmaceutical Company Limited Enterprise-wide Program Core Operating Profit Margin Organizational Agility Data Digital Technology
PRESS RELEASE

published on 10/26/2023 at 08:00, 1 year ago

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2023 (IFRS)

Accesswire

Published on 11/21/2024 at 10:03, 53 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 56 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 56 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 21 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 31 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 26 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 51 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 54 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 56 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 56 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 58 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 36 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 11 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE